SpringWorks shares jump 14%; company plans to seek FDA approval for desmoid tumor therapy this year
Shares of SpringWorks Therapeutics Inc. were up 14.9% in premarket trading on Tuesday after the company said a late-stage clinical trial evaluating its treatment for...